Fig. 13From: Persistent luminescence nanoparticles for cancer theranostics application(Reproduced with permission [119]. Copyright 2019, Wiley–VCH)a Schematic illustration for the design of X-ray activated PLNP-mediated PDT nanoplatform. b Viabilities of HeLa cells with different treatment. c Tumor growth curves of different groups of tumor-bearing mice after various treatments.Back to article page